New initiative seeks investors’ help to tackle antimicrobial resistance

  24 January 2020

A coalition of public and private sector entities is looking to investors to help stem further growth in antimicrobial resistance (AMR).

Investor Year of Action on AMR, as their initiative has been dubbed, was launched in Davos, Switzerland, today, and has as its main objective “to leverage investor influence to make change happen”.

It is backed by the UK’s department of health and social care, Access to Medicine Foundation, the Principles for Responsible Investment, and FAIRR, a non-profit organisation working with investors on the topic of intensive animal production.

Further reading: IPE
Author(s): Susanna Rust
Effective Surveillance   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed